Mechanisms of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid. In vitro studies.
D000818:Animals; D002417:Cattle; D003521:Cyclopropanes / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D005943:Gluconeogenesis / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007005:Hypoglycins / Q000494:pharmacology*; D066298:In Vitro Techniques; D007656:Ketoglutaric Acids / Q000378:metabolism; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010421:Pentanoic Acids / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D051381:Rats
D003521:Cyclopropanes; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D007004:Hypoglycemic Agents; D007005:Hypoglycins; D007656:Ketoglutaric Acids; D010421:Pentanoic Acids; D011773:Pyruvates